Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Immunoreactive endogenous digoxin-like substances : plasma levels are dependent on the hypothalamic-pituitary-adrenal axis for release and on kidney function for elimination

Vinge, E LU ; Erfurth, E M LU and Odar-Cederlöf, I (1993) In Journal of Cardiovascular Pharmacology 22 Suppl 2. p.3-112
Abstract

To identify factors that regulate the levels of immunoreactive digitalis-like substances (irEDLS) in body fluids, two studies were carried out. Plasma and urine levels of irEDLS were measured in uremic and normal subjects. Extracted material was fractionated (12 fractions) and assayed by digoxin radioimmunoassay. In four fractions, higher levels of irEDLS were found in uremic than in normal plasma. Urine from healthy subjects contained very high levels of irEDLS, but in urine collected from uremic patients irEDLS levels were similar to those in plasma. In another study, eight healthy subjects were given dexamethasone 1 mg orally and tetracosactide [an adrenocorticotropic hormone (ACTH) analogue] 0.25 mg i.v., on separate occasions.... (More)

To identify factors that regulate the levels of immunoreactive digitalis-like substances (irEDLS) in body fluids, two studies were carried out. Plasma and urine levels of irEDLS were measured in uremic and normal subjects. Extracted material was fractionated (12 fractions) and assayed by digoxin radioimmunoassay. In four fractions, higher levels of irEDLS were found in uremic than in normal plasma. Urine from healthy subjects contained very high levels of irEDLS, but in urine collected from uremic patients irEDLS levels were similar to those in plasma. In another study, eight healthy subjects were given dexamethasone 1 mg orally and tetracosactide [an adrenocorticotropic hormone (ACTH) analogue] 0.25 mg i.v., on separate occasions. Dexamethasone suppressed the plasma and urine levels of cortisol and irEDLS. ACTH increased the levels of cortisol in plasma and urine, and of irEDLS in plasma. Taken together, these results support the hypothesis that irEDLS are of adrenal origin. However, decreased renal clearance, rather than increased production or release, may be the main cause of increased plasma levels of irEDLS in uremia.

(Less)
Please use this url to cite or link to this publication:
author
; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Administration, Oral, Blood Proteins/metabolism, Cardenolides, Cosyntropin/administration & dosage, Dexamethasone/administration & dosage, Digoxin, Humans, Hydrocortisone/blood, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System/metabolism, Radioimmunoassay, Saponins, Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors, Uremia/metabolism
in
Journal of Cardiovascular Pharmacology
volume
22 Suppl 2
pages
3 - 112
publisher
Lippincott Williams & Wilkins
external identifiers
  • scopus:0027517192
  • pmid:7508014
ISSN
0160-2446
language
English
LU publication?
no
id
2c43bdf1-b67f-453a-822e-868951f06b07
alternative location
https://journals.lww.com/cardiovascularpharm/abstract/1993/22002/immunoreactive_endogenous_digoxin_like_substances_.36.aspx
date added to LUP
2023-11-27 10:15:34
date last changed
2024-01-10 11:54:27
@article{2c43bdf1-b67f-453a-822e-868951f06b07,
  abstract     = {{<p>To identify factors that regulate the levels of immunoreactive digitalis-like substances (irEDLS) in body fluids, two studies were carried out. Plasma and urine levels of irEDLS were measured in uremic and normal subjects. Extracted material was fractionated (12 fractions) and assayed by digoxin radioimmunoassay. In four fractions, higher levels of irEDLS were found in uremic than in normal plasma. Urine from healthy subjects contained very high levels of irEDLS, but in urine collected from uremic patients irEDLS levels were similar to those in plasma. In another study, eight healthy subjects were given dexamethasone 1 mg orally and tetracosactide [an adrenocorticotropic hormone (ACTH) analogue] 0.25 mg i.v., on separate occasions. Dexamethasone suppressed the plasma and urine levels of cortisol and irEDLS. ACTH increased the levels of cortisol in plasma and urine, and of irEDLS in plasma. Taken together, these results support the hypothesis that irEDLS are of adrenal origin. However, decreased renal clearance, rather than increased production or release, may be the main cause of increased plasma levels of irEDLS in uremia.</p>}},
  author       = {{Vinge, E and Erfurth, E M and Odar-Cederlöf, I}},
  issn         = {{0160-2446}},
  keywords     = {{Administration, Oral; Blood Proteins/metabolism; Cardenolides; Cosyntropin/administration & dosage; Dexamethasone/administration & dosage; Digoxin; Humans; Hydrocortisone/blood; Hypothalamo-Hypophyseal System/metabolism; Pituitary-Adrenal System/metabolism; Radioimmunoassay; Saponins; Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors; Uremia/metabolism}},
  language     = {{eng}},
  pages        = {{3--112}},
  publisher    = {{Lippincott Williams & Wilkins}},
  series       = {{Journal of Cardiovascular Pharmacology}},
  title        = {{Immunoreactive endogenous digoxin-like substances : plasma levels are dependent on the hypothalamic-pituitary-adrenal axis for release and on kidney function for elimination}},
  url          = {{https://journals.lww.com/cardiovascularpharm/abstract/1993/22002/immunoreactive_endogenous_digoxin_like_substances_.36.aspx}},
  volume       = {{22 Suppl 2}},
  year         = {{1993}},
}